 |
| Home | About Us | Congress | News | Regions | Publications | Education | Awards | Contact | Join Us | Members |
 |
Welcome to the December issue of your CINP eflyer. In this Issue
|
|
|
Dear CINP Members, I am pleased to welcome you to the first CINP e-flyer. My Presidency of the CINP begins at a time of great controversy, change and opportunity in our field. Today the CINP competes with numerous national and continental organizations for the attention of scientists and clinicians. We must find ways to collaborate and cooperate with other organizations in the field, based on the CINP's unique global perspective. If we wish to celebrate our 100th anniversary in another 50 years we must like so many classic institutions adapt to the rapidly changing world. The public criticism of relationships between physician prescribers, physician scientists and the pharmaceutical industry has reached new heights in recent years. While we may not agree with many of the criticisms we cannot ignore them. The CINP has established a Code of Conduct Committee and a major goal of my Presidency will be to bring this Code of Conduct to acceptance as official policy and to allow its full discussion among our membership and participants in the Hong Kong CINP Congress in 2010. The CINP on this basis can facilitate clinical trials training worldwide. The world is going on line, as we know, and another major goal of my Presidency will be to convert to an online format as many of our membership activities as possible including our membership directory, elections for the Executive Committee and the CINP newsletter to create an international psychopharmacology community. We must include maximally the rapidly developing psychopharmacology science in Asia, where our 2010 meeting will be held. While we partner with a vigorous private pharmaceutical industry, we must also pay attention to countries where large portions of the population have no access to psychopharmacology treatment. I propose a CINP effort to compile a formulary of essential antipsychotic, antidepressant, anxiolytic, mood stabilizer and other treatments that should be available universally even in the poorest countries. The diversity of opinions within our discipline is immense and it is my goal to make sure that the widest possible diversity of opinion be included in our organization to make our meetings exciting and relevant. The CINP's credibility must be unimpeachable even and perhaps especially when new data suggests side effects or reduced efficacy for treatments that we have used widely. We must relate thoughtfully and not competitively to new scientific and clinical trial data on psychotherapeutic and brain stimulation treatments. The rapidly expanding neurosciences have as we know not yet been always translated into clinically effective patient treatments. We hope the CINP meetings will be a place where thoughtful clinicians and clinician scientists can be inspired from new neuroscience developments to create heuristic clinical hypotheses. The founding generation of the CINP and its followers (and I say this as someone whose first CINP meeting was 30 years ago!) are rapidly reaching retirement age. We must devote ourselves to fully including in all of our activities a strong younger generation. Prof. Robert H. Belmaker 
CINP Thematic Meeting on Major Psychoses & Substance Abuse 
Edinburgh, CINP Thematic Meeting 25th-27th April 2009 An innovative and exciting new format of CINP meeting begins in 2009. The Thematic meeting is focused on a single theme, concentrating on specific topics and incorporating educational and professional developement in addition to research sessions. The first such CINP Thematic Meeting is to be held at the Edinburgh International Conference Centre, Edinburgh, Scotland , UK, one of the world's leading capital cities with dramatic setting and vibrant culture. Edinburgh has an unprecedented range of cultural choices, exceptional art galleries, museums, restaurants and pubs. Delegates who are able to add a day or two on to their visit will be delighted to know that the rest of Scotland is literally on their doorstep. With castles steeped in history, golf, fishing, skiing, shopping and distillery tours to choose from, it's impossible to fit it all in. Chairman Prof W Wolfgang Fleischhacker Early bird Delegate Rate on/before 30th January 2009 Delegate Rate after 30th January 2009 Onsite Delegate Rate after 18th April 2009 More information and registration forms www.northernnetworking.co.uk Sponsorship opportunities still available Hong Kong, CINP World Congress 6th-10th June 2010 
It is our houour to invite psychopharmacologists around the world to attend the XXVII Congress of the CINP to be held in Hong Kong, China. The congress will alow senior and junior psychopharmacology researchers from Europe and North America to acquaint themselves with the rapidly increasing numbers of talented investigators in China and other Asian nations. Moreover, the XXVII CINP congress will include programme topics such as ethics of clinical trials, conflict of interest in psychopharmacology developement, and developement of nutriceuticals in addition to the traditional CINP programme. Hong Kong is a highly developed international city with multi-Asian and Western elements. Hong Kong has a lot to offer to visitors, from ancient temples, great museums, beautiful parks to sublime shopping centres and markets. Two billion people live within a short flight from Hong Kong and 3,000 delegates are expected at the Congress from all over the world. Local Organising Committee Chairman S W Tang Deadline for symposia proposal submissions 2nd March 2009 Deadline for early registration fee 15th January 2010 Deadline for poster abstracts submission 2nd Febuary 2010 Deadline for late registration fee 15th May 2010 More information at www.cinp2010.com The CINP is pleased to announce the establishment of a prize in Ethics in Psychopharmacology to be given biennially at the major congress in parallel with the other international CINP sponsored prizes. The prize applications will be judged by an international committee of experts in this field and will recognize achievements in research in ethics in psychopharmacology, in promotion of public awareness of ethics in psychopharmacology and contributions to the solution of problems in ethical practice of psychopharmacology. While ethics involves all of human behavior, including medicine and medical research, psychopharmacology raises numerous sensitive ethical issues related to the very essence of human nature. Areas included for consideration in this prize include 1) ethics of scientific responsibility in publishing in psychopharmacology, 2) conflict of interest in clinical research, 3) treatment of research subjects both human and animal, 4) informed consent in psychopharmacology research and 5) doctor patient relationships in psychopharmacology. Applicants must be nominated by a CINP member and include a CV and a one to three page statement of the justification of the nomination. All submissions should be received by December 31, 2009 and addressed to the Ethics Prize Committee care of CINP Executive Secretary Gill Moore (cinp@glasconf.demon.co.uk) . Email submissions are preferable.
XXVI CINP Congress, Munich, Germany, 13 – 17 July 2008 CINP celebrated its 50th anniversary in Munich with the XXVI CINP Congress. Three thousand from 85 countries attended the meeting at the beautiful, modern and light-flooded Internationales Congress Centre Munchen. Twenty six exhibitors with a total of 170 staff were present in the foyer on the ground floor and the exhibition hall which covered 1,029 sqm of exhibition space. In total 895 posters were presented in the poster area approximately 300 per day. The poster presentations in the evening, complemented by a Wine & Cheese Mixer, were well attended. In a dedicated section the Mentee / Rafaelsen Award Posters were displayed on all three congress days. The social programme started off with a symposium on “The History of Psychiatry in Munich” which took participants to the Department of Psychiatry at the Ludwig-Maximilians-University and the Max-Planck-Institute of Psychiatry. On Sunday evening the congress was officially opened followed by the Welcome Reception in the exhibition areas. The Opening Ceremony was a wonderful blend of classical music, performed by both psychiatrists and the a-capella ensemble Nostalphoniker, the celebration of CINP’s 50th anniversary, a ceremonial lecture, honorary citations and an awards ceremony. The Welcome Reception featured traditional Bavarian folk music and typical Bavarian food. The Scientific Programme covered all aspects of treatment of CNS disorders from basic to clinical research, and the newest concepts for improving the life of patients with mental and neurological disorders were presented. Dan Rujescu 
CINP President-elect H J Möller was honoured by the World Psychiatry Association at its recent World congress in Prague with the Jean Delay Prize, one of the highest honours a psychiatrist can receive. 
REPORT OF THE CINP EDUCATION COMMITTEE
A second workshop was held in September in Buenos Aires in conjunction with the annual congress of the Latin American College of Neuropsychopharmacology ( CLANP). This consisted of a one day workshop for approximately 50 young psychiatrists and pharmacologists. This session was conducted by Brian Leonard and covered both basic and clinical psychopharmacology of antidepressants, antipsychotics, anxiolytics and mood stabilisers. A 2 hour interactive workshop formed an essential part of the programme. This was followed by a 2 hour session on the ethics of clinical trials conducted by Angelos Halaris. The final workshop for 2008 will be held as part of the Eastern/Central European Regional CINP meeting in Bratislava at the end of November 2008. A half-day workshop for young psychopharmacologists and psychiatrists will be organised by Angelos Halaris and Brian Leonard, together with senior members of the local organising committee. This programme will also cover advances in basic and clinical psychopharmacology. A one-day workshop was held in Volgograd in early September. Approximately 100 young pharmacologists and psychiatrists attended the workshop addressed by S.Seredenin (on novel anxiolytics), E.Valdman( on the importance of the P450 system in the kinetics of psychotropic drugs) A.M.Zharkovsky ( on the impact of molecular biology on depression research) and Brian Leonard ( on the future of antidepressant research). The Russian workshops have been held under the auspices of the Russian Academy of Medical Science. The committee and its activities need to change with the times and develop if it is to have a greater impact among young psychiatrists, neuroscientists and psychopharmacologists. In particular, there is a need to extend our educational activities into more of the developing countries, particularly Africa. This has been actively pursued in the past (workshops have been held in South Africa, Namibia, Uganda, Kenya) but there is a need to organise more sustained courses in the near future. It must be remembered that, despite the financial constraints under which we are operating at present, the mission of the CINP is to develop psychopharmacology world-wide. Brian E. Leonard Gillian E M Moore – New CINP Executive Secretary 
Gill Moore has recently been appointed as the Executive Secretary for CINP. Gill Moore has extensive working knowledge in the international CNS field. She started working with Dr Alec Coppen in 1987 in the administration of his Affective Disorders clinic at West Park Hospital in Epsom, Surrey, UK. She became involved with the CINP when Dr Coppen became President Elect. She continued as Assistant to the President during the Presidency of Professors Julian Mendlewicz, Giorgio Racagni, and Lewis Judd. In 1996-98 she was Executive Secretary for the Local Organising Committee for the XXIst CINP Comgress which took place in Glasgow in 1998. In 2004 Prof Brian Leonard invited her to assist him during his Presidency of CINP. In 2006 Northern Networking Events, an Association Management and Professional Conference Organising Company headed by Gill Moore contracted with CINP. Gill Moore has served a number of clients in different areas of association management and stand alone conferences. Her interests in the CNS field have stretched over 20 years with many of the key opinion leaders in the field. She maintains excellent contacts within the pharmaceutical industry and has an extensive knowledge of conference organisation. She is assisted in the office by Cara McIlwraith, June Harpum and David Massey who all work for the benefit of CINP membership and leadership. Please feel free to contact the CINP central office team on cinp@glasconf.demon.co.uk
|
|
|
 |
|